Latest News Archive

Please select Category, Year, and then Month to display items
Years
2019 2020 2021 2024
Previous Archive
18 July 2019 | Story Julian Roup | Photo Leonie Bolleurs
Clear glass
UFS researchers Lucas Erasmus (left), researcher in the UFS Department of Physics and Prof Hendrik Swart, senior professor in the UFS Department of Physics and SARChI chair (South African Research Chairs Initiative) in Solid State Luminescent and Advanced Materials, with the equipment used for the ground-breaking research.

A revolutionary new type of window glass – in effect a transparent solar panel - is the objective of joint research being done by the University of the Free State (UFS) in South Africa and Ghent University in Belgium. 

A working model has been created which proves the viability of the process which now needs to be refined, made more efficient and brought to the market. It is hoped to achieve this within a decade.

This new product will have the capacity to revolutionise the generation of power cheaply from the sun to power homes, factories and cities in a new clean way.

Academics from the UFS, Prof Hendrik Swart and Lucas Erasmus are doing joint research with Ghent University in Belgium, to find solutions for energy production. 

The two universities entered into an agreement recently for this research into electricity generation. The research is driven by the UFS and was prompted by ever-rising electricity prices and growing demand for electricity production. South Africa lives with constant power outages which leaves people stuck in lifts and facing chaos on the roads as traffic lights cut out. Many people who can afford them now rely on generators.

Prof Hendrik Swart, senior professor in the Department of Physics at the University of the Free State and SARChI chair (South African Research Chairs Initiative) in Solid State Luminescent and Advanced Materials, says: “An innovation like this which can help to replace traditional means of carbon based fuel for power generation in our daily lives would be hugely welcome.”

Swart explains the main objective of the research: “The idea is to develop glass that is transparent to visible light, just like the glass you find in the windows of buildings, motor vehicles and mobile electronic devices. However, by incorporating the right phosphor materials inside the glass, the light from the sun that is invisible to the human eye (ultraviolet and infrared light) can be collected, converted and concentrated to the sides of the glass panel where solar panels can be mounted. 

This invisible light can then be used to generate electricity to power buildings, vehicles and electronic devices. The goal is therefore to create a type of transparent solar panel.”

Swart says this technology can be implemented in the building environment to meet the energy demands of the people inside the buildings. “The technology is also good news for the 4.7 billion cell phone users in the world, as it can be implemented in the screens of cell phones, where the sun or the ambient light of a room can be used to power the device without affecting its appearance,” he said.

Another possible application is in electric cars, where the windows can be used to help power the vehicle.

Lucas Erasmus who is working with Prof Swart adds: “We are also looking at implementing this idea into hard, durable plastics that can act as a replacement for zinc roofs. This will allow visible diffused light to enter housing and the invisible light can then be used to generate electricity. The device also concentrates the light from a large area to the small area on the sides where the solar panels are placed; therefore, reducing the number of solar panels needed and in return, reducing the cost.”

It is envisaged that the technology will take about a decade to refine and implement. This study is currently on-going, and UFS are experimenting and testing different materials in order to optimise the device in the laboratory. It then needs to be upscaled in order to test it in the field. “It is truly the technology of the future,” says 
Erasmus.

The UFS envisages that the end result of this research will provide an attractive solution to address the energy demands of buildings, electric motor vehicles and mobile electronics without affecting their appearance. 

According to Swart, the agreement entails a joint doctoral degree in which both universities will supervise the project and the awarding of the doctorate. Lucas Erasmus, a student at the UFS, has been tasked with the assignment to conduct research at both institutions.

News Archive

Science is diversifying the uses of traditional medicines
2017-07-17

Description: Dr Motlalepula Matsabisa  Tags: traditional medicines, Indigenous Knowledge Systems, Dr Motlalepula Matsabisa, Malaria, priority disease  

Dr Motlalepula Matsabisa.
Photo: Anja Aucamp

According to the World Health Organisation, a large majority of the African population are making use of traditional medicines for health, socio-cultural, and economic purposes. In Africa, up to 80% of the population uses traditional medicines for primary healthcare.

The Indigenous Knowledge Systems (IKS) was identified as a lead programme under the directorship of Dr Motlalepula Matsabisa. Research undertaken by the IKS Lead Programme focuses on some key priority diseases of the country and region – including malaria, HIV, cancer, and diabetes.
 
Not just a plant or tree

Malaria is a priority disease and is prevalent in rural and poor areas, resulting in many traditional health practitioners claiming to treat and cure the disease. There may well be substance to these claims, since as much as 30% of the most effective current prescription medicines are derived from plants.  For instance, chloroquine, artemisinin for malaria, Metformin for diabetes, Vincristine and Vinblastine for cancer, are plant-derived drugs.  

Dr Matsabisa’s current research is investigating a South African medicinal plant that has been shown to have in vitro antiplasmodial activity, with subsequent isolation and characterisation of novel non-symmetrical sesquiterpene lactone compounds offering antimalarial activity. These novel compounds are now patented in South Africa and worldwide. This research is part of the UFS and South Africa’s strive to contribute to the regional and continental malaria problem. The UFS are thus far the only university that has been granted a permit by the Medicines Control Council to undertake research on cannabis and its potential health benefits.

“All of these projects are aimed
at adding value through the scientific
research of medicinal plants, which
can be used for treating illnesses,
diseases, and ailments.”

Recognition well deservedThrough Dr Matsabisa’s research input and contributions to the development of the pharmacology of traditional medicines, he recently became the first recipient of the International Prof Tuhinadrin Sen Award from the International Society of Ethnopharmacology (ISE) and the Society of Ethnopharmacology in India. ISE recognises outstanding contributions by researchers, scientists, and technologists in the area of medicinal plant research and ethnopharmacology internationally.

More recently, Dr Matsabisa undertook research projects funded by the National Research Foundation, as well as the Department of Science and Technology, on cancer, gangrene, and diabetes. He is also involved in a community project to develop indigenous teas with the community. He says, “All of these projects are aimed at adding value through the scientific research of medicinal plants, which can be used for treating illnesses, diseases, and ailments”.

Dr Matsabisa has worked with many local and international scientists on a number of research endeavours. He is grateful to his colleagues from the Department of Pharmacology in the Faculty of Health Sciences, who are dedicated to science research and the research of traditional medicines. The IKS unit also received immense support from the Directorate of Research Development.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept